Share this video  

SABCS 2022 | SABCS 2022 key takeaways: optimizing treatment sequencing strategies

Kim Blenman, PhD, MS, Yale School of Medicine, New Haven, CT, discusses the application of liquid biopsies, including with circulating tumor cells (CTCs), cytokines and autoantibody profiling, to monitor treatment response as well as treatment toxicity. This interview took place at the San Antonio Breast Cancer Symposium (SABCS) 2022 in San Antonio, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.